- Summary
- Here's a summary of the website content:
Two months ahead of schedule, recruitment of 220 patients for the PROSPER study is complete – a Phase II clinical trial for supranuclear palsy (PSP). Additionally, Nature Medicine published data from a Phase 3 trial of pridopidine in early-stage Huntington’s disease, highlighting its impact on clinical progression. - Title
- Home | Ferrer
- Description
- Home | Ferrer
- Keywords
- section, para, people, planet, action, good, great, collective, footer, canal, principal, pipeline, apis, business, development, english, nederlands
- NS Lookup
- A 54.76.85.231
- Dates
-
Created 2026-03-07Updated 2026-03-07Summarized 2026-03-08
Query time: 742 ms